Mad Money

Cramer: You'll miss out if you ignore these giant stock buybacks

Key Points
  • "Mad Money" host Jim Cramer highlights large share repurchase programs at Apple, Boeing and others.
  • In a market that's grown sour on buybacks, it's important to remember how good they are for investors, Cramer says.
Ignore these giant stock buybacks and you'll miss out
VIDEO1:0701:07
Ignore these giant stock buybacks and you'll miss out

When Apple's Tuesday evening earnings report brought the idea of huge stock buybacks back into Wall Street's good graces, CNBC's Jim Cramer was thrilled.

"I've been wondering: what exactly does it take for a company to get Wall Street to appreciate its fabulous earnings and its numbers for revenues?" the "Mad Money" host said on Wednesday. "It's not just Apple that's buying back stock like there's no tomorrow."

The iPhone maker's plan to return up to $100 billion to its shareholders marks the largest share repurchase program announced this year.

But Cramer pointed to five other companies — Amgen, Oracle, Microsoft, Boeing and UnitedHealth Group — that have also announced huge buyback programs, only to be brushed off by market-watchers.

"It's like people don't even notice, which is why I feel compelled ... to point out some of the best ones," Cramer said. "So let's talk about the biggest, most impactful buybacks we've seen."

1. Amgen

Before Apple announced that it spent $22.8 billion in actual buybacks last quarter, setting a record, biopharmaceutical colossus Amgen was in the lead.

Amgen, the biggest independent biotechnology company in the world, said it bought back $10.7 billion worth of stock last quarter — seven times bigger than its 2017 buyback and an 8.5 percent decrease in its total share count.

"Yet even though the Amgen buyback was a thing of beauty, it didn't seem to have much impact on the stock price, as the darned thing keeps trending lower and lower because biotech's a hated cohort," Cramer said.

"Honestly, if they keep repurchasing at this pace and the stock refuses to go higher or even goes lower, ... this could get on the list of companies being taken over," he added.

2. Oracle

Software giant Oracle bought back $4 billion worth of stock last quarter, but Cramer thought the company's $70 billion pile of cash could've warranted an even larger buyback.

"Oracle seems to feel like the market doesn't appreciate the quality of its business, so they're taking action," he explained. "Given the not-so-hot results from the latest quarter, ... I'm not sure management necessarily is right, but at least the guys are putting their money where their mouth is."

3. Microsoft

Microsoft's $3.8 billion buyback may have marked an 88 percent year-over-year jump, but it still paled in comparison to the tech company's $718 billion market cap.

"Still, Microsoft's been a great performer and the buyback has made its stock behave like it's a small-cap enterprise: when buyers come in, they can't seem to get enough so they move the stock up big," the "Mad Money" host said. "That's what happened when it reported last week."

4. Boeing

Fourth in line was aircraft manufacturer Boeing, which repurchased $3 billion of its shares in the first quarter.

If Boeing's incredibly strong demand remains intact despite the ongoing U.S.-China trade dispute, Cramer could see the $324 stock flying to $400.

"Boeing looks like a steal to me," Cramer said. "Clearly, Boeing's management agrees with me, which is why they're in there buying this stock back hand over fist."

5. UnitedHealth Group

Cramer chalked up UnitedHealth Group's $2.65 billion buyback, a 710 percent increase versus 2017, to the fact that business is good at the managed health care colossus.

"Their managed care competitors are being sold or combining — basically, UNH often feels like the only player in the group that's totally got its house in order," the "Mad Money" host explained.

As sellers rotated out of UnitedHealth Group's stock and into shares of Centene on Wednesday after the latter announced its own buyback, Cramer spotted an opportunity in UnitedHealth.

"I think you need to view this weakness as a gift," he said.

Circling back

Finally, Cramer circled back to Apple's "buyback to end all buybacks." He was glad to see the consumer tech company finally put a significant piece of its $267 billion cash hoard to work.

He was even happier to hear Apple CFO Luca Maestri say on the post-earnings conference call that the company believes its stock is undervalued.

"That's music to my ears," Cramer said. "I'm a huge fan of this move. Luca Maestri has made it clear that Apple's going to be disciplined with its purchase, but he also said they wanted to deploy the capital quickly. And, look, having Apple buying vast quantities of its own stock is going to make this stock a lot easier to own, even up here."

And considering the fact that Apple has bought back $200 billion worth of its own stock over the last six years, Cramer was confident Apple CEO Tim Cook and his team could execute.

"Bottom line? Today, Apple got credit for its bountiful buyback plans, but there are tons of other companies returning huge slugs of cash to their shareholders and I think you'll miss out if you ignore them," the "Mad Money" host concluded. "Do some homework, find the ones you want to buy and then snag them before the companies buy up all the shares themselves."

WATCH: Cramer finds promising, buyback-happy stocks

Cramer: You'll miss out if you ignore these giant stock buybacks
VIDEO11:3211:32
Cramer: You'll miss out if you ignore these giant stock buybacks

Disclosure: Cramer's charitable trust owns shares of Apple, Microsoft and UnitedHealth Group.

Questions for Cramer?
Call Cramer: 1-800-743-CNBC

Want to take a deep dive into Cramer's world? Hit him up!
Mad Money Twitter - Jim Cramer Twitter - Facebook - Instagram - Vine

Questions, comments, suggestions for the "Mad Money" website? madcap@cnbc.com